Virbac SA (EPA:VIRP)
France · Delayed Price · Currency is EUR 304.50
-3.00 (-0.98%)
Sep 23, 2026, 5:35 PM CET
Virbac Market Cap
Virbac has a market cap or net worth of €2.55 billion as of September 23, 2026. Its market cap has decreased by -3.33% in one year.
Market Cap
2.55B
Enterprise Value
2.75B
Revenue
1.49B
Ranking
n/a
PE Ratio
16.37
Stock Price
€304.50
ChartMarket Cap Chart
Since August 8, 1994, Virbac's market cap has increased from 217.52M to 2.55B, an increase of 1,072.79%. That is a compound annual growth rate of 7.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 2.55B | -14.83% |
| Dec 31, 2025 | 3.00B | 13.00% |
| Dec 31, 2024 | 2.65B | -12.68% |
| Dec 29, 2023 | 3.04B | 57.52% |
| Dec 30, 2022 | 1.93B | -46.24% |
| Dec 31, 2021 | 3.58B | 78.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 88.72B |
| EssilorLuxottica Société anonyme | 63.88B |
| Sartorius Stedim Biotech | 19.27B |
| Eurofins Scientific SE | 13.27B |
| bioMérieux | 8.43B |
| ABIVAX Société Anonyme | 7.93B |
| emeis Société anonyme | 1.91B |
| Nanobiotix | 1.52B |